» Articles » PMID: 9078991

Use of Benzodiazepines in Panic Disorder

Overview
Specialty Psychiatry
Date 1997 Jan 1
PMID 9078991
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past 15 years, benzodiazepines have been used successfully to treat panic disorder with agoraphobia, but not without some controversy. Efficacy and side effect data from the principal benzodiazepine outcome studies of panic disorder demonstrate that alprazolam, lorazepam, and clonazepam are all clinically effective. Clonazepam has several advantages over other benzodiazepines and can be considered a first-line agent for panic disorder. Benzodiazepines in general are therapeutically effective for a broad range of panic disorder symptoms. Their effect is rapid and maintained without dose increase over a 7- to 8-month period. Discontinuation-related difficulties can occur in a considerable number of patients, but these can be decreased in several ways.

Citing Articles

Site specific binding pattern of benzodiazepines with GABA receptor and related impact on their activities in the human body: An in silico method based study.

Roy M, Sarkar B, Kundu S Heliyon. 2024; 10(13):e33929.

PMID: 39071685 PMC: 11283148. DOI: 10.1016/j.heliyon.2024.e33929.


Treatment of noncardiac chest pain of psychological origin.

Olden K Curr Treat Options Gastroenterol. 2006; 9(1):51-8.

PMID: 16423313 DOI: 10.1007/s11938-006-0023-6.


Three year naturalistic outcome study of panic disorder patients treated with paroxetine.

Dannon P, Iancu I, Cohen A, Lowengrub K, Grunhaus L, Kotler M BMC Psychiatry. 2004; 4:16.

PMID: 15191617 PMC: 441384. DOI: 10.1186/1471-244X-4-16.


A risk-benefit assessment of pharmacological treatments for panic disorder.

Bennett J, Moioffer M, Stanton S, Dwight M, Keck Jr P Drug Saf. 1998; 18(6):419-30.

PMID: 9638387 DOI: 10.2165/00002018-199818060-00003.


Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: behavioral studies with concomitant in vivo CA1 hippocampal norepinephrine and serotonin release detection in the behaving animal.

Broderick P, Hope O, Jeannot P Prog Neuropsychopharmacol Biol Psychiatry. 1998; 22(2):353-86.

PMID: 9608607 PMC: 7131360. DOI: 10.1016/s0278-5846(98)00010-4.